Entity family
Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.
This drug is selected. Its supporting articles are shown below.
… anti-TNF when starting their first advanced treatment (such as vedolizumab [VDZ]) and describe their demographics/clinical characteristics…
…Introduction Elective discontinuation of Vedolizumab (VDZ) may be considered in patients achieving deep remission, b…
…uired minor adjustment. Templates of moderate duration included ustekinumab, vedolizumab, and adalimumab counselling, with completion times…
…elective immunosuppressive therapy (SIT) such as infliximab and vedolizumab. The aim of our study was to assess for factors predicting need…
…iatric population of people living with IBD treated with either infliximab or vedolizumab who were recruited to the UK CLARITY IBD to stud…
…re recorded. At the end of follow-up, two patients continued on risankizumab monotherapy, while three maintained the combination therapy.Con…
…everity, and management of irAEs in melanoma patients receiving ipilimumab–nivolumab therapy.Material and Methods A retrospective observat…
…h anti-IL23-naïve individuals and those previously treated with Ustekinumab, in real-world clinical practice at a tertiary hospital.Materia…
…id-free clinical and biomarker remission). All patients receive vedolizumab according to the standard dosing regimen, with an additional do…
…eutic drug monitoring. The patient was subsequently switched to vedolizumab and has since shown good clinical response. This case underscor…
…Introduction Biologic therapies, such as vedolizumab (VDZ) and ustekinumab (UST), offer effective treatment options for inflammatory bowel…
… non-overlapping pathways (eg, anti-tumour necrosis factor with vedolizumab or ustekinumab; Janus Kinase (JAK) inhibitors with gut-selectiv…